Development and validation of a comprehensive genomic diagnostic tool for myeloid malignancies

T. McKerrell, L. T. Moreno, H. Ponstingl, N. Bolli, J.M.L. Dias, G. Tischler, Vincenza Colonna, B. Manasse, A. Bench, D. Bloxham, B. Herman, D. Fletcher, H. N. Park, Michael A. Quail, N. Manes, Clare Hodkinson, J. Baxter, J. I. Sierra, Theodora Foukaneli, Alan J. WarrenW. J. Chi, P. Costeas, R. Hooshmand-Rad, B. J P Huntly, C. Grove, Zemin Ning, Chris Tyler-Smith, I. Varela, Andrew M. Scott, J. Nomdedeu, V. Mustonen, G.S. Vassiliou

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)E1-E9
JournalBlood
Volume128
Issue number1
DOIs
Publication statusPublished - 2016

Cite this

McKerrell, T., Moreno, L. T., Ponstingl, H., Bolli, N., Dias, J. M. L., Tischler, G., Colonna, V., Manasse, B., Bench, A., Bloxham, D., Herman, B., Fletcher, D., Park, H. N., Quail, M. A., Manes, N., Hodkinson, C., Baxter, J., Sierra, J. I., Foukaneli, T., ... Vassiliou, G. S. (2016). Development and validation of a comprehensive genomic diagnostic tool for myeloid malignancies. Blood, 128(1), E1-E9. https://doi.org/10.1182/blood-2015-11-683334